FCGR2A Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P12318 |
---|---|
Clone Names | 100427124 |
Gene ID | 2212 |
---|---|
Other Names | Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a, CDw32, Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a, CD32, FCGR2A, CD32, FCG2, FCGR2A1, IGFR2 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13724b was selected from the C-term region of FCGR2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | FCGR2A |
---|---|
Synonyms | CD32, FCG2, FCGR2A1, IGFR2 |
Function | Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Found on monocytes, neutrophils and eosinophil platelets |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes one member of a family of immunoglobulinFc receptor genes found on the surface of many immune responsecells. The protein encoded by this gene is a cell surface receptorfound on phagocytic cells such as macrophages and neutrophils, andis involved in the process of phagocytosis and clearing of immunecomplexes. Alternative splicing results in multiple transcriptvariants.
References
Dornan, D., et al. Blood 116(20):4212-4222(2010)Zhang, C.Y., et al. J. Biol. Chem. 285(44):34250-34258(2010)Iwasaki, M., et al. Breast Cancer Res. Treat. (2010) In press :Ho-Pun-Cheung, A., et al. Pharmacogenomics J. (2010) In press :Sfar, I., et al. Arch Inst Pasteur Tunis 86 (1-4), 51-62 (2009) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.